Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628)

Benita S Katzenellenbogen, J. A. Katzenellenbogen, E. R. Ferguson, N. Krauthammer

Research output: Contribution to journalArticle

Abstract

Radiolabeled anti-estrogen α-[4-pyrrolidinoethoxy]phenyl-4- methoxy-α'-nitrostilbene ([3H]CI-628) of high specific activity (16 Ci/mmol) and radiochemical purity (>95%) has been prepared by catalytic tritium-iodine exchange and purified by alumina column chromatography. Its interaction with estrogen receptors in immature (day 20 to 24) rat uterus is studied in vitro and in vivo. [3H]CI-628 (CI) competes with estra-1,3,5(10-triene-3,17β-diol (estradiol (E2)) for binding to specific cytoplasmic estrogen receptors, but has a lower binding affinity (CI: K(d) = 1.7 x 10-9 M; E2: K(d) = 1 x 10-10 M, at 0-4°, determined at equilibrium by charcoal/dextran adsorption). Both [3H]CI and [3H]E2 have similar rates of association with the receptor (CI: k(+1) = 5.5 x 105 M-1 s-1; E2: k(+1) = 4.4 x 105 M-1 s-1, at 0-4°), but [3H]CI dissociates much more rapidly (CI: k(-1) = 2.6 x 10-4 s-1, t(1/2) = 44 min; E2: k(-1) = 2.4 x 10-6 s-1, t(1/2) = 80 h, at 0-4°). Different sedimentation profiles are seen for the cytoplasmic receptor complexes with [3H]CI and with [3H]E2 on low salt sucrose density gradients: over 90% of the [3H]E2 receptor complexes sediment at 8.0 S, whereas 70% of the [3H]CI receptor complexes (estrogen-compatible sites) sediment at 4.5 S, only 30% sedimenting a 8.0 S. After administration of [3H]CI in vivo, radioactivity can be found associated with specific estrogen-receptor sites in uterine nuclei. Salt-extracted nuclear receptor [3H]CI complexes sediment at 5.4 S on 0.4 M KCl sucrose gradients as do [3H]E2 nuclear receptor complexes. Thin layer chromatographic analysis of ethyl acetate extracts of the nuclear receptor peak fractions from sucrose gradients shows that a polar metabolite of CI-628 is selectively bound to the 5.4 S receptor. Pharmacokinetic studies reveal that high levels of unmetabolized CI persist in serum and uterus for long periods of time (half-cleared in 18 to 24 hr), whereas E2 is much more rapidly cleared (half-cleared in 30 min). These results indicate that in many respects, [3H]CI-628 and [3H]E2 interact with the estrogen receptor in a parallel manner; however, certain properties of the antiestrogen receptor complex are different from those of the estradiol receptor complex. Further, it is likely that the prolonged in vivo activity of this antiestrogen derives, at least in part, from its slow rate of clearance and that the agent active in vivo may be a metabolite of CI-628.

Original languageEnglish (US)
Pages (from-to)697-707
Number of pages11
JournalJournal of Biological Chemistry
Volume253
Issue number3
StatePublished - Dec 1 1978

Fingerprint

Nitromifene
Cytoplasmic and Nuclear Receptors
Estrogen Receptors
Estrogens
Sucrose
Sediments
Estrogen Receptor Modulators
Metabolites
Uterus
Salts
Estradiol Receptors
Thin layer chromatography
Column chromatography
Pharmacokinetics
Tritium
Aluminum Oxide
Charcoal
Radioactivity
Thin Layer Chromatography
Dextrans

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628). / Katzenellenbogen, Benita S; Katzenellenbogen, J. A.; Ferguson, E. R.; Krauthammer, N.

In: Journal of Biological Chemistry, Vol. 253, No. 3, 01.12.1978, p. 697-707.

Research output: Contribution to journalArticle

@article{026dd996c29845ec8cf8aed9c7b3b54d,
title = "Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628)",
abstract = "Radiolabeled anti-estrogen α-[4-pyrrolidinoethoxy]phenyl-4- methoxy-α'-nitrostilbene ([3H]CI-628) of high specific activity (16 Ci/mmol) and radiochemical purity (>95{\%}) has been prepared by catalytic tritium-iodine exchange and purified by alumina column chromatography. Its interaction with estrogen receptors in immature (day 20 to 24) rat uterus is studied in vitro and in vivo. [3H]CI-628 (CI) competes with estra-1,3,5(10-triene-3,17β-diol (estradiol (E2)) for binding to specific cytoplasmic estrogen receptors, but has a lower binding affinity (CI: K(d) = 1.7 x 10-9 M; E2: K(d) = 1 x 10-10 M, at 0-4°, determined at equilibrium by charcoal/dextran adsorption). Both [3H]CI and [3H]E2 have similar rates of association with the receptor (CI: k(+1) = 5.5 x 105 M-1 s-1; E2: k(+1) = 4.4 x 105 M-1 s-1, at 0-4°), but [3H]CI dissociates much more rapidly (CI: k(-1) = 2.6 x 10-4 s-1, t(1/2) = 44 min; E2: k(-1) = 2.4 x 10-6 s-1, t(1/2) = 80 h, at 0-4°). Different sedimentation profiles are seen for the cytoplasmic receptor complexes with [3H]CI and with [3H]E2 on low salt sucrose density gradients: over 90{\%} of the [3H]E2 receptor complexes sediment at 8.0 S, whereas 70{\%} of the [3H]CI receptor complexes (estrogen-compatible sites) sediment at 4.5 S, only 30{\%} sedimenting a 8.0 S. After administration of [3H]CI in vivo, radioactivity can be found associated with specific estrogen-receptor sites in uterine nuclei. Salt-extracted nuclear receptor [3H]CI complexes sediment at 5.4 S on 0.4 M KCl sucrose gradients as do [3H]E2 nuclear receptor complexes. Thin layer chromatographic analysis of ethyl acetate extracts of the nuclear receptor peak fractions from sucrose gradients shows that a polar metabolite of CI-628 is selectively bound to the 5.4 S receptor. Pharmacokinetic studies reveal that high levels of unmetabolized CI persist in serum and uterus for long periods of time (half-cleared in 18 to 24 hr), whereas E2 is much more rapidly cleared (half-cleared in 30 min). These results indicate that in many respects, [3H]CI-628 and [3H]E2 interact with the estrogen receptor in a parallel manner; however, certain properties of the antiestrogen receptor complex are different from those of the estradiol receptor complex. Further, it is likely that the prolonged in vivo activity of this antiestrogen derives, at least in part, from its slow rate of clearance and that the agent active in vivo may be a metabolite of CI-628.",
author = "Katzenellenbogen, {Benita S} and Katzenellenbogen, {J. A.} and Ferguson, {E. R.} and N. Krauthammer",
year = "1978",
month = "12",
day = "1",
language = "English (US)",
volume = "253",
pages = "697--707",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "3",

}

TY - JOUR

T1 - Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628)

AU - Katzenellenbogen, Benita S

AU - Katzenellenbogen, J. A.

AU - Ferguson, E. R.

AU - Krauthammer, N.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - Radiolabeled anti-estrogen α-[4-pyrrolidinoethoxy]phenyl-4- methoxy-α'-nitrostilbene ([3H]CI-628) of high specific activity (16 Ci/mmol) and radiochemical purity (>95%) has been prepared by catalytic tritium-iodine exchange and purified by alumina column chromatography. Its interaction with estrogen receptors in immature (day 20 to 24) rat uterus is studied in vitro and in vivo. [3H]CI-628 (CI) competes with estra-1,3,5(10-triene-3,17β-diol (estradiol (E2)) for binding to specific cytoplasmic estrogen receptors, but has a lower binding affinity (CI: K(d) = 1.7 x 10-9 M; E2: K(d) = 1 x 10-10 M, at 0-4°, determined at equilibrium by charcoal/dextran adsorption). Both [3H]CI and [3H]E2 have similar rates of association with the receptor (CI: k(+1) = 5.5 x 105 M-1 s-1; E2: k(+1) = 4.4 x 105 M-1 s-1, at 0-4°), but [3H]CI dissociates much more rapidly (CI: k(-1) = 2.6 x 10-4 s-1, t(1/2) = 44 min; E2: k(-1) = 2.4 x 10-6 s-1, t(1/2) = 80 h, at 0-4°). Different sedimentation profiles are seen for the cytoplasmic receptor complexes with [3H]CI and with [3H]E2 on low salt sucrose density gradients: over 90% of the [3H]E2 receptor complexes sediment at 8.0 S, whereas 70% of the [3H]CI receptor complexes (estrogen-compatible sites) sediment at 4.5 S, only 30% sedimenting a 8.0 S. After administration of [3H]CI in vivo, radioactivity can be found associated with specific estrogen-receptor sites in uterine nuclei. Salt-extracted nuclear receptor [3H]CI complexes sediment at 5.4 S on 0.4 M KCl sucrose gradients as do [3H]E2 nuclear receptor complexes. Thin layer chromatographic analysis of ethyl acetate extracts of the nuclear receptor peak fractions from sucrose gradients shows that a polar metabolite of CI-628 is selectively bound to the 5.4 S receptor. Pharmacokinetic studies reveal that high levels of unmetabolized CI persist in serum and uterus for long periods of time (half-cleared in 18 to 24 hr), whereas E2 is much more rapidly cleared (half-cleared in 30 min). These results indicate that in many respects, [3H]CI-628 and [3H]E2 interact with the estrogen receptor in a parallel manner; however, certain properties of the antiestrogen receptor complex are different from those of the estradiol receptor complex. Further, it is likely that the prolonged in vivo activity of this antiestrogen derives, at least in part, from its slow rate of clearance and that the agent active in vivo may be a metabolite of CI-628.

AB - Radiolabeled anti-estrogen α-[4-pyrrolidinoethoxy]phenyl-4- methoxy-α'-nitrostilbene ([3H]CI-628) of high specific activity (16 Ci/mmol) and radiochemical purity (>95%) has been prepared by catalytic tritium-iodine exchange and purified by alumina column chromatography. Its interaction with estrogen receptors in immature (day 20 to 24) rat uterus is studied in vitro and in vivo. [3H]CI-628 (CI) competes with estra-1,3,5(10-triene-3,17β-diol (estradiol (E2)) for binding to specific cytoplasmic estrogen receptors, but has a lower binding affinity (CI: K(d) = 1.7 x 10-9 M; E2: K(d) = 1 x 10-10 M, at 0-4°, determined at equilibrium by charcoal/dextran adsorption). Both [3H]CI and [3H]E2 have similar rates of association with the receptor (CI: k(+1) = 5.5 x 105 M-1 s-1; E2: k(+1) = 4.4 x 105 M-1 s-1, at 0-4°), but [3H]CI dissociates much more rapidly (CI: k(-1) = 2.6 x 10-4 s-1, t(1/2) = 44 min; E2: k(-1) = 2.4 x 10-6 s-1, t(1/2) = 80 h, at 0-4°). Different sedimentation profiles are seen for the cytoplasmic receptor complexes with [3H]CI and with [3H]E2 on low salt sucrose density gradients: over 90% of the [3H]E2 receptor complexes sediment at 8.0 S, whereas 70% of the [3H]CI receptor complexes (estrogen-compatible sites) sediment at 4.5 S, only 30% sedimenting a 8.0 S. After administration of [3H]CI in vivo, radioactivity can be found associated with specific estrogen-receptor sites in uterine nuclei. Salt-extracted nuclear receptor [3H]CI complexes sediment at 5.4 S on 0.4 M KCl sucrose gradients as do [3H]E2 nuclear receptor complexes. Thin layer chromatographic analysis of ethyl acetate extracts of the nuclear receptor peak fractions from sucrose gradients shows that a polar metabolite of CI-628 is selectively bound to the 5.4 S receptor. Pharmacokinetic studies reveal that high levels of unmetabolized CI persist in serum and uterus for long periods of time (half-cleared in 18 to 24 hr), whereas E2 is much more rapidly cleared (half-cleared in 30 min). These results indicate that in many respects, [3H]CI-628 and [3H]E2 interact with the estrogen receptor in a parallel manner; however, certain properties of the antiestrogen receptor complex are different from those of the estradiol receptor complex. Further, it is likely that the prolonged in vivo activity of this antiestrogen derives, at least in part, from its slow rate of clearance and that the agent active in vivo may be a metabolite of CI-628.

UR - http://www.scopus.com/inward/record.url?scp=0018090976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018090976&partnerID=8YFLogxK

M3 - Article

C2 - 621199

AN - SCOPUS:0018090976

VL - 253

SP - 697

EP - 707

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 3

ER -